More importantly, we have learned that molecules such as kinases (CaMK4) or transcription factors (CREM/ICER) which had previously been linked to abnormal effector T cell function in SLE accomplish their effects by directly controlling the function of metabolic enzymes involved in glycolysis and glutaminolysis. This evidence concerns the gene CREM and systemic lupus erythematosus.